432 related articles for article (PubMed ID: 26322226)
1. The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.
Ngo ST; Steyn FJ
Cell Regen; 2015; 4(1):5. PubMed ID: 26322226
[TBL] [Abstract][Full Text] [Related]
2. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tefera TW; Steyn FJ; Ngo ST; Borges K
Cell Biosci; 2021 Jan; 11(1):14. PubMed ID: 33431046
[TBL] [Abstract][Full Text] [Related]
3. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
4. Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression.
Ioannides ZA; Ngo ST; Henderson RD; McCombe PA; Steyn FJ
Neurodegener Dis; 2016; 16(5-6):382-97. PubMed ID: 27400276
[TBL] [Abstract][Full Text] [Related]
5. Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy.
Do-Ha D; Buskila Y; Ooi L
Mol Neurobiol; 2018 Feb; 55(2):1410-1418. PubMed ID: 28160214
[TBL] [Abstract][Full Text] [Related]
6. Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis.
Zhou W; Xu R
Front Neurosci; 2023; 17():1189470. PubMed ID: 37638324
[TBL] [Abstract][Full Text] [Related]
7. K
Vidal-Taboada JM; Pugliese M; Salvadó M; Gámez J; Mahy N; Rodríguez MJ
Mol Neurobiol; 2018 Oct; 55(10):7962-7972. PubMed ID: 29492846
[TBL] [Abstract][Full Text] [Related]
8. What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy.
Manzano R; Toivonen JM; Moreno-Martínez L; de la Torre M; Moreno-García L; López-Royo T; Molina N; Zaragoza P; Calvo AC; Osta R
Br J Pharmacol; 2021 Mar; 178(6):1279-1297. PubMed ID: 32986860
[TBL] [Abstract][Full Text] [Related]
9. Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.
Carlesi C; Pasquali L; Piazza S; Lo Gerfo A; Caldarazzo Ienco E; Alessi R; Fornai F; Siciliano G
Arch Ital Biol; 2011 Mar; 149(1):151-67. PubMed ID: 21412722
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic Lateral Sclerosis Model.
Azuma Y; Mizuta I; Tokuda T; Mizuno T
Adv Exp Med Biol; 2018; 1076():79-95. PubMed ID: 29951816
[TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?
Scaricamazza S; Salvatori I; Ferri A; Valle C
Cells; 2021 Mar; 10(3):. PubMed ID: 33801336
[TBL] [Abstract][Full Text] [Related]
12. Amyotrophic lateral sclerosis: current understanding.
Charles T; Swash M
J Neurosci Nurs; 2001 Oct; 33(5):245-53. PubMed ID: 11668883
[TBL] [Abstract][Full Text] [Related]
13. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis.
Parboosingh JS; Meininger V; McKenna-Yasek D; Brown RH; Rouleau GA
Arch Neurol; 1999 Jun; 56(6):710-2. PubMed ID: 10369311
[TBL] [Abstract][Full Text] [Related]
14. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.
Nijssen J; Comley LH; Hedlund E
Acta Neuropathol; 2017 Jun; 133(6):863-885. PubMed ID: 28409282
[TBL] [Abstract][Full Text] [Related]
15. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
Perera ND; Turner BJ
Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of amyotrophic lateral sclerosis.
Talbott EO; Malek AM; Lacomis D
Handb Clin Neurol; 2016; 138():225-38. PubMed ID: 27637961
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive review of amyotrophic lateral sclerosis.
Zarei S; Carr K; Reiley L; Diaz K; Guerra O; Altamirano PF; Pagani W; Lodin D; Orozco G; Chinea A
Surg Neurol Int; 2015; 6():171. PubMed ID: 26629397
[TBL] [Abstract][Full Text] [Related]
19. New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target?
Gonzalez-Fernandez C; González P; Rodríguez FJ
Neural Regen Res; 2020 Sep; 15(9):1580-1589. PubMed ID: 32209757
[TBL] [Abstract][Full Text] [Related]
20. Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.
Merwin SJ; Obis T; Nunez Y; Re DB
Arch Toxicol; 2017 Aug; 91(8):2939-2952. PubMed ID: 28070599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
